Exercise Reverses Cognitive Decline In Aged Animals By Growth Hormone Stimulation Of Neurogenesis In The Hippocampus
Funder
National Health and Medical Research Council
Funding Amount
$696,409.00
Summary
The production of new neurons in the hippocampus plays a critical role in learning and memory. With increasing age, this production slows and is associated with cognitive decline. However the stem cells that make new neurons are still present, and we have discovered that exercise activates these cells, leading to renewed neuron production and reversal of cognitive decline. We will explore how this process is regulated in order to develop strategies to reduce cognitive decline in humans.
Optimising Exercise Prescription For Brain Health In Older Adults At Risk Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$594,123.00
Summary
To reduce dementia burdens in the community, cost effective and targeted early regenerative strategies are critical. Engaging in frequent aerobic exercise is one strategy that can delay the onset and slow the progression of dementia. However, prescription is limited by an incomplete understanding of how exercise positively influences brain health. Here I will investigate the influence of current exercise levels, intensity and exercise environment on brain health in adults at risk of dementia.
Strengthening Functional Connectivity In The Ageing Brain.
Funder
National Health and Medical Research Council
Funding Amount
$320,891.00
Summary
Age-related deficits in the ability to perform meaningful, voluntary movements markedly increase the likelihood of experiencing falls, a major cause of injury among older adults. Using advanced neurophysiological techniques, this project will (1) define the role of functional connectivity decline in age-related movement deficits and (2) gain a mechanistic understanding of improvements in voluntary movement control through a promising intervention for reversing age-related functional decline.
Long-term Physical Exercise Improves Cognitive Performance Through Neuroimmune Modulation
Funder
National Health and Medical Research Council
Funding Amount
$493,586.00
Summary
This research investigates for how long exercise needs to carried out in order to be beneficial for cognitive function. We choose an animal model which simulates chronic brain inflammation as seen during aging processes of humans and during many inflammatory diseases affecting brain function. This research will unravel the long-term immunomodulatory and protective effects of exercise on brain function as well as the short-term anti-inflammatory effects on brain function.
Connectivity Of Regenerating Axons Following Spinal Cord Injury
Funder
National Health and Medical Research Council
Funding Amount
$586,428.00
Summary
Our objective is to thoroughly investigate the connections made by regenerating nerve fibres in mice which are treated with specific compounds to inhibit scarring as well as with active exercise following spinal cord injury. This will provide evidence of the potential of these compounds as a therapeutic intervention. Understanding how the nervous system rewires following exercise intervention will provide insights as to how new connections can be shaped to ensure optimal recovery of function.
The Role Of Metals In Healthy Brain Aging: Identification Of Novel Compounds To Prevent Age-related Cognitive Decline
Funder
National Health and Medical Research Council
Funding Amount
$789,733.00
Summary
This grant will explore the basic mechanisms that underlie normal learning and memory. Specifically, we are focussing on how the modulation of metal levels may occur with age, and how this may cause or at least contribute to age-related cognitive impairment. We are also examining a novel therapeutic compound for the treatment of cognitive dysfunction. This work will have implications for both normal and pathological ageing.
Electrical Stimulation With A “Random Noise” Pattern: A New Approach For The Treatment Of Depression
Funder
National Health and Medical Research Council
Funding Amount
$523,160.00
Summary
This study is a world first, examining the use of a novel technology to treat depression by stimulating the brain mildly and non invasively. The study will examine the effectiveness of a 4-week course of Transcranial “Random Noise” Stimulation to treat depression, and will also measure whether improvement in mood is accompanied by a restoration of brain plasticity or adaptability.
Biomaterials For The Direct Reprograming Of Reactive Astrocytes Into Functional Neurons
Funder
National Health and Medical Research Council
Funding Amount
$630,500.00
Summary
We will employ peptide inspired hydrogel nanoscaffolds that can be injected into a brain lesion as a single injection to provide chemical and physical support for the surrounding cells. We will utilize various modifications to these materials to reprogram inflammatory cells into neurons, whilst also promoting the survival, maintenance and growth of existing neurons to encourage repair.
Molecular Imaging To Advance Treatment Of Dementia
Funder
National Health and Medical Research Council
Funding Amount
$412,419.00
Summary
Molecular imaging using a scan technique called positron emission tomography, enables detection and measurement of specific pathological features of disease such as the amyloid plaques of Alzheimer’s disease. This project will develop this technology for other aspects of brain disorders including dementias, Parkinson’s disease, traumatic brain injury and schizophrenia and use it to assist development of therapies and improve clinical diagnosis nation wide.
Precision Treatment For Multiple Sclerosis: Maximising The Effect Of Immunomodulatory Therapy
Funder
National Health and Medical Research Council
Funding Amount
$537,272.00
Summary
Response to therapy varies greatly among patients with multiple sclerosis (MS). The current lack of individualised MS therapy may lead to suboptimal MS management and accumulation of preventable disability. We will use MSBase, a large international MS cohort, to evaluate the effect of different treatment strategies and of highly effective and novel therapies. Identifying the patients who will benefit from these therapies, we will provide the key evidence for individualised MS management.